Navigation Links
Hospital-acquired infections -- Inevitable?

In a press conference held earlier today at Washington D.C.'s The Press Club, David B. Nash, MD, editor of The American Journal of Medical Quality, addressed hospital-acquired infections and the widespread anchoring belief ?by both healthcare professionals and patients ?that acquiring infections in the hospital is unavoidable.

This concern is addressed in a special supplement to the November issue of The American Journal of Medical Quality, which is published by SAGE Publications on behalf of the American College of Medical Quality.

The data seems to bear out the pervasive belief. In 2004, Pennsylvania's general acute care hospitals reported nearly 12,000 hospital-acquired infections (HAIs). These were associated with over 1,500 additional deaths, 205,000 additional hospital days, and nearly $2 billion in extra hospital charges. While many healthcare professionals believe that HAI are a risk of doing business, the AJMQ supplement demonstrates that the belief itself may add to the risk and it's actually the process of care that drives the current epidemic.

"Despite all of our hard work, medical care can never be error free," commented Dr. Nash about the widespread beliefs about HAI. "What we must strive for is care that is harm free. Changing our mindset will go a long way toward restoring the faith of the public and improving the overall quality of medical care in the United States."

"I sincerely hope that this special supplement to the American Journal of Medical Quality will help us to obtain this worthy goal," Dr. Nash added. The supplement can be accessed by visiting The American Journal of Medical Quality website at http://ajmq.sagepub.com.


'"/>

Source:SAGE Publications


Page: 1

Related biology news :

1. Bacteria collection sheds light on urinary tract infections
2. Scientists decipher genome of fungus that can cause life-threatening infections
3. Light therapy may combat fungal infections, new evidence suggests
4. New strategies to reduce hospital-aquired infections
5. New insight into autoimmune disease: Bacterial infections promote recognition of self-glycolipids
6. High rates of sexually transmitted infections found in young drug users
7. Quantum dots provide a faster, more sensitive method for detecting respiratory viral infections
8. Eliminating bacterial infections out of thin air
9. New vaccine platform may fight infections with causes from influenza to bioterrorism
10. Infant transplant patients resist infections that kill adult AIDS patients
11. World first research to speed up cure for ear infections
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: